Form 4: Verizon Executive Kyle Malady Sells 8,000 Shares of Common Stock
SEC Form 4 Filing
EVP and Group CEO of Verizon Business, Kyle Malady, sold 8,000 shares of Verizon Communications Inc. common stock at a price of $39.885 on February 3, 2025.
Summary
- On February 3, 2025, Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., sold 8,000 shares of common stock at $39.885 per share.
- Following the transaction, Malady directly owns 6,590 shares of Verizon common stock.
- Malady also indirectly owns 18,415 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for executives at publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although it is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 02/03/2025 | Date of the stock sale transaction. |
| 02/05/2025 | Date of signature by Attorney-in-fact. |
Keywords
Form 4, Verizon, Stock Sale, Executive, Malady, VZ
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.